You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

residual plasma IM concentration

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Venetoclax Plasma Concentration and Remission in Acute Myeloid

Not yet recruiting
  • Adult Acute Myeloid Leukemia
  • Blood sampling for venetoclax drug dosage (venous puncture)
  • (no location specified)
Sep 13, 2023

Healthy Volunteers Trial in New Haven (NaxRedy ™, Naloxone Hydrochloride Injection, USP)

Completed
  • Healthy Volunteers
  • NaxRedy ™
  • Naloxone Hydrochloride Injection, USP
  • New Haven, Connecticut
    New Haven Clinical Research Unit
Mar 2, 2022

17-OHPC in Pregnancy: IM vs SC Routes

Recruiting
  • Preterm Birth
  • 17-Hydroxyprogesterone Caproate 250 mg IM Dose
  • 17-Hydroxyprogesterone Caproate 275 mg SC Dose
  • Newark, Delaware
  • +3 more
Feb 2, 2022

Multiple Myeloma Trial in Worldwide (Daratumumab, Bortezomib, Lenalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Whittier, California
  • +113 more
Jan 17, 2023

Severe Influenza Trial in Créteil (Absorption test)

Not yet recruiting
  • Severe Influenza
  • Absorption test
  • Créteil, France
    Anne-Fleur Haudebourg
Dec 7, 2022

NAD Trial in Berlin (Niagen, Placebo)

Not yet recruiting
  • NAD
  • Niagen
  • Placebo
  • Berlin, Germany
    Surgical Clinic, Campus Virchow-Klinikum / Campus Charité Mitte,
Aug 22, 2023

SARS-CoV-2 Trial in Winston-Salem, San Antonio (ADM03820, Placebo)

Active, not recruiting
  • SARS-CoV-2
  • Winston-Salem, North Carolina
  • +1 more
Feb 1, 2023

Kidney Tumor Trial in France (blood sampling for ITK dosage)

Recruiting
  • Kidney Neoplasm
  • blood sampling for ITK dosage
  • Marseille, France
  • +4 more
Jan 6, 2023

UPLC-MS/MS Monitoring of Emicizumab Therapy

Not yet recruiting
  • Hemophilia A
    • Caen, France
    • +1 more
    Mar 14, 2022

    Cesarean Section Complications, Uterine Bleeding, Pelvic Pain Trial (Platelet Rich Plasma)

    Not yet recruiting
    • Cesarean Section Complications
    • +3 more
    • Platelet Rich Plasma
    • (no location specified)
    Nov 10, 2022

    Acute Lymphoblastic Leukemia (ALL) Trial in Worldwide (Carfilzomib, Dexamethasone, Mitoxantrone)

    Recruiting
    • Acute Lymphoblastic Leukemia (ALL)
    • Orange, California
    • +86 more
    Nov 14, 2022

    End Stage Renal Disease, Haemodialysis, Diet, Healthy Trial in Ljubljana (medium cut-off (MCO) dialysis membrane, Dietary fiber

    Recruiting
    • End Stage Renal Disease
    • +2 more
    • medium cut-off (MCO) dialysis membrane
    • +2 more
    • Ljubljana, Slovenia
      University Medical Center ljubljana
    May 17, 2022

    Human Immunodeficiency Virus Type 1 (HIV-1) Trial in Worldwide (Cabotegravir - Injectable Suspension (CAB LA), Rilpivirine -

    Active, not recruiting
    • Human Immunodeficiency Virus Type 1 (HIV-1)
    • Cabotegravir - Injectable Suspension (CAB LA)
    • Rilpivirine - Injectable Suspension (RPV LA)
    • Macon, Georgia
    • +29 more
    May 31, 2023

    Leukemia, Myeloid, Chronic-Phase Trial in Bordeaux (Imatinib Mesylate 600 MG Oral Tablet, Imatinib Mesylate 400 MG Oral Tablet,

    Terminated
    Has Results
    • Leukemia, Myeloid, Chronic-Phase
    • Imatinib Mesylate 600 MG Oral Tablet
    • +2 more
    • Bordeaux, Aquitaine, France
      Institut Bergonié
    Dec 30, 2020

    Opioid-use Disorder Trial in New York (Naltrexone 380 MG)

    Active, not recruiting
    • Opioid-use Disorder
    • Naltrexone 380 MG
    • New York, New York
      Columbia University Medical Center
    Jul 1, 2022

    Infections Trial in Ghent (device, diagnostic test, other)

    Not yet recruiting
    • Infections
    • Prediction of plasma concentration of piperacillin-tazobactam or meropenem
    • +2 more
    • Ghent, Belgium
      University Hospital, Ghent
    Sep 4, 2023

    Diabetes, Type 2 Trial in San Antonio (Dapagliflozin, Exenatide, Placebo)

    Active, not recruiting
    • Diabetes Mellitus, Type 2
    • San Antonio, Texas
      University of Texas Health Science Center
    Sep 12, 2022

    Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (GSK744, GSK744 LA, TMC278 LA)

    Active, not recruiting
    Has Results
    • Infection, Human Immunodeficiency Virus
    • HIV Infections
    • Birmingham, Alabama
    • +49 more
    Dec 26, 2022

    Imatinib With Hepatic Resection or Other Local Treatment for

    Completed
    • GIST, Malignant
    • Liver Metastases
    • imatinib (IM)
    • +3 more
    • Guangzhou, Guangdong, China
      The First Affiliated Hospital of Sun Yat-sen University
    Sep 12, 2023

    Breast Cancer, Triple Negative Breast Cancer Trial in United States (Capecitabine, Talazoparib, Atezolizumab)

    Recruiting
    • Breast Cancer
    • Triple Negative Breast Cancer
    • Washington, District of Columbia
    • +5 more
    Jan 12, 2023

    HIV Trial in Glendale (Cabotegravir Tablets, Rilpivirine Tablets, Cabotegravir extended release suspension for injection

    Completed
    • HIV Infections
    • Cabotegravir Tablets
    • +3 more
    • Glendale, California
      GSK Investigational Site
    Feb 14, 2022

    HIV Trial in New Zealand, United States (Cabotegravir sodium (Oral Lead In), Cabotegravir 400 mg/mL, Cabotegravir 200 mg/mL)

    Recruiting
    • HIV Infections
    • Cabotegravir sodium (Oral Lead In)
    • +6 more
    • Orlando, Florida
    • +4 more
    Mar 29, 2022

    Anti-Glomerular Basement Membrane Antibody Disease Trial in Worldwide (Imlifidase)

    Completed
    Has Results
    • Anti-Glomerular Basement Membrane Antibody Disease
    • Imlifidase
    • Innsbruck, Austria
    • +9 more
    Feb 7, 2022

    Trace Elements Concentration in Dialysis

    Not yet recruiting
    • Dialysis
      • Boulogne-Billancourt, France
        Nephrology Department and Dialysis Unit
      Sep 9, 2021

      Peritoneal Dialysis Complication, End Stage Kidney Disease, Sodium-glucose Co-transporter-2 Inhibitors Trial in Toronto

      Not yet recruiting
      • Peritoneal Dialysis Complication
      • +4 more
      • Empagliflozin 25 MG
      • Toronto, Ontario, Canada
        Toronto General Hospital
      Jan 27, 2023